SpringWorks Therapeutics Announces Data to be Presented at the 2024 American Society of ...
– Results from pivotal Phase 2b ReNeu trialofmirdametinib in patients with NF1-PN to be presented in an oral presentation –
Source: eagletribune.com
Stay updated with breaking news from Christopherl Moertel. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
– Results from pivotal Phase 2b ReNeu trialofmirdametinib in patients with NF1-PN to be presented in an oral presentation –
The large Danish study found no association, and the low increase in absolute risk with nonoral progestin-only injections could be a result of chance.